Klinische trials

Convergence 203-study
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy.
Primary Investigator Isala: W. Brinkert, Anesthesiologist

PROTILL-study
Protein intake, gastro intestinal tolerance and safety after administration of a new high protein tube feed in critically ill overweight ICU patients as compared to an isocaloric standard tube feed.
Primary Investigator Isala: H. Kieft, Intensivist

Stepp-study
Safety and gastrointestinal Tolerance after administration of an energy and proteïn enriched peptide formula in ICU patients as compared to an isocaloric standard tube feed.

Primary Investigator Isala: H. Kieft, Intensivist

PROTECt-study
Prospectieve studie naar de logistieke gevolgen en kosten van isolatie in het kader van infectiepreventie  in IC’s in Nederland.
Primairy INvestigator Isala: H. Sonneveld, Anesthesiologist, Intensivist.

Nebulae-study
Efficiency of routine nebulisation in mechanical ventilated patients in the Intensive Care Unit.
Primairy Investigator Isala: J. Haringman, Intensivist

Influenza-study
A phanse 2 randomized, double blind placebo-controlled trial of MHAA4549A, a monoclonal antibody, in combination with oseltamivir versus oseltamivir for treatment of severe influenza infection.
Primairy Investigator Isala: H. Sonneveld, Anesthesiologist/Intensivist

Voyager study
Vascular outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (PAD).

Coöperation with Department Surgery. Primary Investigator Isala: W. Fritschy, surgeon.